GAMCO INVESTORS, INC. ET AL - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$41,769
+6.1%
18,900
+21.9%
0.00%
Q1 2023$39,370
+35.8%
15,5000.0%0.00%
Q4 2022$28,985
-77.2%
15,500
-68.7%
0.00%
-100.0%
Q3 2022$127,000
+32.3%
49,5000.0%0.00%0.0%
Q2 2022$96,000
-34.7%
49,5000.0%0.00%0.0%
Q1 2022$147,000
-33.2%
49,500
+1.0%
0.00%
-50.0%
Q4 2021$220,000
+33.3%
49,000
+44.1%
0.00%
+100.0%
Q3 2021$165,000
+79.3%
34,000
+161.5%
0.00%0.0%
Q1 2021$92,000
+13.6%
13,0000.0%0.00%0.0%
Q4 2020$81,000
+5.2%
13,000
-8.5%
0.00%0.0%
Q3 2020$77,000
-70.0%
14,200
-71.1%
0.00%
-66.7%
Q2 2020$257,000
+46.9%
49,200
-11.7%
0.00%
+50.0%
Q1 2020$175,000
-21.9%
55,7000.0%0.00%0.0%
Q4 2019$224,000
-7.1%
55,7000.0%0.00%0.0%
Q3 2019$241,000
+8.6%
55,7000.0%0.00%0.0%
Q2 2019$222,000
-28.6%
55,700
-4.0%
0.00%0.0%
Q1 2019$311,000
+2.6%
58,000
-1.7%
0.00%
-33.3%
Q4 2018$303,00059,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders